Literature DB >> 4811053

Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

T A Connors, P J Cox, P B Farmer, A B Foster, M Jarman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4811053     DOI： 10.1016/0006-2952(74)90318-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  57 in total

1.  A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients.

Authors:  M Hassan; U S Svensson; P Ljungman; B Björkstrand; H Olsson; M Bielenstein; M Abdel-Rehim; C Nilsson; M Johansson; M O Karlsson
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Basic principles in preclinical cancer chemotherapy.

Authors:  N Brock; J Pohl; B Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 3.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

Authors:  M D Bacolod; S M Lin; S P Johnson; N S Bullock; M Colvin; D D Bigner; H S Friedman
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

5.  The effect of age on the pharmacokinetics of ifosfamide.

Authors:  M J Lind; J M Margison; T Cerny; N Thatcher; P M Wilkinson
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

6.  Tissue distribution and nucleic acid binding of chlorambucil-3H in tumor-bearing rats.

Authors:  K D Tew; D M Taylor
Journal:  Experientia       Date:  1978-09-15

7.  Antineoplastic activity of ASTA Z 7557 (INN mafosfamide) in transplanted and autochthonous experimental rodent tumors.

Authors:  W J Zeller; M R Berger; R Matys; J Schuhmacher
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

8.  A comparative study of therapeutic activity, myelotoxicity and DNA damage in the bone marrow of mice after cyclophosphamide and ASTA Z 7557 (INN mafosfamide).

Authors:  M R Berger; P Bedford; W J Zeller; M Kaufmann
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

9.  Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy.

Authors:  Eniko Bodó; Desmond J Tobin; York Kamenisch; Tamás Bíró; Mark Berneburg; Wolfgang Funk; Ralf Paus
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Preclinical pharmacokinetics and stability of isophosphoramide mustard.

Authors:  J J Zheng; K K Chan; F Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.